Related Experiment Videos
Development of disintegrating multiple-unit tablets on a high-speed rotary tablet press
K G Wagner1, M Krumme, T E Beckert
1Institut für Pharmazie, Universität Tübingen, Tübingen, Germany.
Summary
Tablet compression of enteric-coated bisacodyl pellets requires careful control. Using Avicel PH 101 as a filler-binder and reducing pellet content to 60% ensures tablet integrity and meets USP 23 dissolution standards.
Area of Science:
- Pharmaceutical Technology
- Drug Delivery Systems
- Tablet Manufacturing
Background:
- Enteric-coated bisacodyl pellets are formulated into disintegrating tablets.
- Tablet compression can potentially damage the enteric coating, affecting drug release.
- Evaluating pellet integrity during tablet manufacturing is crucial for product quality.
Purpose of the Study:
- To investigate the impact of tablet compression parameters on enteric-coated bisacodyl pellets.
- To identify optimal filler-binders and tablet press settings for minimizing pellet damage.
- To ensure the final tablet formulation meets United States Pharmacopeia (USP) 23 dissolution requirements.
Main Methods:
- Compression of enteric-coated bisacodyl pellets into divisible tablets using a high-speed rotary tablet press.
- Assessment of pellet damage through bisacodyl dissolution testing under acidic conditions (USP 23).
- Image analysis of colored pellets to evaluate homogeneous distribution within tablets.
Main Results:
- Tablet compression parameters and filler-binder type significantly influenced pellet damage.
- Avicel PH 101 was identified as the most suitable filler-binder, promoting homogeneous pellet distribution.
- Tablets with 70% coated pellets failed USP 23 requirements, while reducing to 60% ensured compliance (<10% bisacodyl release in 2h acid treatment).
Conclusions:
- Avicel PH 101 is effective in minimizing pellet damage during high-speed tablet compression.
- Reducing the proportion of enteric-coated bisacodyl pellets to 60% (w/w) is necessary to meet USP 23 dissolution standards.
- Optimized tablet formulation and manufacturing processes are essential for enteric-coated drug delivery systems.